Adefovir-resistant hepatitis B can be associated with viral rebound and hepatic decompensation
Open Access
- 7 July 2005
- journal article
- Published by Elsevier BV in Journal of Hepatology
- Vol. 43 (6), 937-943
- https://doi.org/10.1016/j.jhep.2005.05.037
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- 57 Long-term incidence of adefovir dipivoxil (ADV) resistance in chronic hepatitis B (CHB) patients after 144 weeks of therapyJournal of Hepatology, 2004
- Long-term safety of lamivudine treatment in patients with chronic hepatitis BGastroenterology, 2003
- Resistance to adefovir dipivoxil therapy associated with the selection of a novel mutation in the HBV polymeraseGastroenterology, 2003
- Week 48 resistance surveillance in two phase 3 clinical studies of adefovir dipivoxil for chronic hepatitis BHepatology, 2003
- Hepatitis B viral resistance: mechanisms and diagnosisJournal of Hepatology, 2003
- Histological outcome during long-term lamivudine therapyGastroenterology, 2003
- Extended lamivudine treatment in patients with chronic hepatitis B enhances hepatitis B e antigen seroconversion rates: Results after 3 years of therapyHepatology, 2001
- The Impact of Drug Resistance on the Effectiveness of Chemotherapy for Chronic Hepatitis BHepatology, 2000
- Effects of extended lamivudine therapy in Asian patients with chronic hepatitis BGastroenterology, 2000
- Identification and characterization of mutations in hepatitis B virus resistant to lamivudineHepatology, 1998